Therapeutic strategy targeting the mTOR-HIF-1α-VEGF pathway in ovarian clear cell adenocarcinoma
-
- MIYAZAWA Masaki
- Department of Pathology, Tokai University School of Medicine
-
- YASUDA Masanori
- Department of Pathology, Saitama Medical University International Medical Center
-
- FUJITA Mariko
- Department of Pathology, Tokai University School of Medicine
-
- KAJIWARA Hiroshi
- Department of Pathology, Tokai University School of Medicine
-
- HIRABAYASHI Kenichi
- Department of Pathology, Tokai University School of Medicine
-
- TAKEKOSHI Susumu
- Department of Pathology, Tokai University School of Medicine
-
- HIRASAWA Takeshi
- Department of Obstetrics and Gynecology, Tokai University School of Medicine
-
- MURAKAMI Masaru
- Department of Obstetrics and Gynecology, Tokai University School of Medicine
-
- OGANE Naoki
- Division of Pathology, Kanagawa Cancer Center
-
- KIGUCHI Kazushige
- Department of Obstetrics and Gynecology, St Marianna University School of Medicine
-
- ISHIWATA Isamu
- Institute of Cell Biology, Ishiwata Obstetrics and Gynecological Hospital
-
- MIKAMI Mikio
- Department of Obstetrics and Gynecology, Tokai University School of Medicine
-
- OSAMURA R. Yoshiyuki
- Department of Pathology, Tokai University School of Medicine
この論文をさがす
収録刊行物
-
- Pathology international
-
Pathology international 59 (1), 19-27, 2009-01-01
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1571698601184683008
-
- NII論文ID
- 10027378890
-
- NII書誌ID
- AA10984364
-
- ISSN
- 13205463
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles
- KAKEN